Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck

Executive Summary

Chairman Roy Vagelos receives $1 mil. in salary in 1993, 10% less than 1992 per his April 1 recommendation to board, Merck proxy statement says. Vagelos received an annual bonus of $1.2 mil., 14% less than in 1992. Merck's long term incentive program, however, paid Vagelos $1.3 mil. The LTIP pays out every other year based on performance for the preceding five years. Vagelos received no stock options during 1993; in 1992 he received a "special one-time grant" of 500,000 shares in lieu of future grants and base salary increases. The award was made in recognition that "he would reach the company's mandatory retirement age in 1994"

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024308

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel